(Q34476913)

2 August 2017

1 reference

title

Effect of nonnicotine pharmacotherapy on smoking behavior (English)

1 reference

2 August 2017

0 references

Kotlyar M

1

1 reference

2 August 2017

Golding M

series ordinal

2

1 reference

2 August 2017

Hatsukami DK

series ordinal

3

1 reference

2 August 2017

Jamerson BD

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

12

1 reference

2 August 2017

page(s)

1530-1548

1 reference

Smoking, smoking cessation, and major depression

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Depression and the dynamics of smoking. A national perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A randomized trial of nortriptyline for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nicotine patch and paroxetine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Efficacy of buspirone in smoking cessation: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A randomized trial of naltrexone for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

The effects of phenylpropanolamine on dietary intake, physical activity, and body weight after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effects of phenylpropanolamine on withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

The effect of bupropion on nicotine craving and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Cigarette craving, smoking withdrawal, and clonidine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Naltrexone, smoking behaviour and cigarette withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Naltrexone administration affects ad libitum smoking behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

The effect of d-amphetamine and ephedrine on smoking attitude and behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Is clonidine an effective smoking cessation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Therapeutic applications of bromocriptine in endocrine and neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Bromocriptine reduces cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Dexfenfluramine. An updated review of its therapeutic use in the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Buspirone: future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effects of 5-hydroxytryptamine3 antagonist, ondansetron, on cigarette smoking, smoke exposure, and mood in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Endogenous opioids and smoking: a review of progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Drug therapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effect of naloxone on cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Naloxone does not affect cigarette smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Naltrexone blockade of nicotine effects in cigarette smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Smoking cessation and severity of weight gain in a national cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Cigarette smoking and subjective response: Effects of d-amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Effects of caffeine on cigarette smoking and subjective response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nicotine intake in smokers increases following a single dose of haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Understanding brain mechanisms in nicotine reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nicotine self-administration in animals and humans: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Biological aspects of the link between smoking and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nicotine effects on adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Nortriptyline in the treatment of ADHD: a chart review of 58 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Use of moclobemide in children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

Depression, anxiety, and smoking initiation: a prospective study over 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.20.1530.34477

10.1592/PHCO.21.20.1530.34477

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference